Suppr超能文献

小儿功能性腹痛疾病的非药物治疗方法。

Non-pharmacologic approaches to treatment of pediatric functional abdominal pain disorders.

作者信息

Chakraborty Partha Sarathi, Daniel Rhea, Navarro Fernando A

机构信息

Department of Pediatrics, Division of Gastroenterology, Hepatology and Nutrition, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, United States.

出版信息

Front Pediatr. 2023 Jun 15;11:1118874. doi: 10.3389/fped.2023.1118874. eCollection 2023.

Abstract

Functional abdominal pain disorders (FAPDs) affect up to 25% of children in the United States. These disorders are more recently known as disorders of "brain-gut" interaction. The diagnosis is based on the ROME IV criteria, and requires the absence of an organic condition to explain the symptoms. Although these disorders are not completely understood, several factors have been involved in the pathophysiology including disordered gut motility, visceral hypersensitivity, allergies, anxiety/stress, gastrointestinal infection/inflammation, as well dysbiosis of the gut microbiome. The pharmacologic and non-pharmacologic treatments for FAPDs are directed to modifying these pathophysiologic mechanisms. This review aims to summarize the non-pharmacologic interventions used in the treatment of FAPDs including dietary modifications, manipulation of the gut microbiome (neutraceuticals, prebiotics, probiotics, synbiotics and fecal microbiota transplant) and psychological interventions that addresses the "brain" component of the brain-gut axis (cognitive behavioral therapy, hypnotherapy, breathing and relaxation techniques). In a survey conducted at a large academic pediatric gastroenterology center, 96% of patients with functional pain disorders reported using at least 1 complementary and alternative medicine treatment to ameliorate symptoms. The paucity of data supporting most of the therapies discussed in this review underscores the need for large randomized controlled trials to assess their efficacy and superiority compared to other treatments.

摘要

功能性腹痛障碍(FAPDs)在美国影响着多达25%的儿童。这些障碍最近被称为“脑-肠”相互作用障碍。诊断基于罗马IV标准,且需要排除能解释症状的器质性疾病。尽管这些障碍尚未被完全理解,但病理生理学涉及多个因素,包括肠道动力紊乱、内脏高敏感性、过敏、焦虑/压力、胃肠道感染/炎症以及肠道微生物群失调。FAPDs的药物和非药物治疗旨在改变这些病理生理机制。本综述旨在总结用于治疗FAPDs的非药物干预措施,包括饮食调整、肠道微生物群的调控(营养保健品、益生元、益生菌、合生元和粪便微生物群移植)以及针对脑-肠轴“脑”部分的心理干预(认知行为疗法、催眠疗法、呼吸和放松技巧)。在一家大型学术性儿科胃肠病中心进行的一项调查中,96%的功能性疼痛障碍患者报告使用了至少一种补充和替代医学疗法来缓解症状。本综述中讨论的大多数疗法缺乏数据支持,这突出表明需要进行大型随机对照试验,以评估它们与其他治疗方法相比的疗效和优势。

相似文献

1
Non-pharmacologic approaches to treatment of pediatric functional abdominal pain disorders.
Front Pediatr. 2023 Jun 15;11:1118874. doi: 10.3389/fped.2023.1118874. eCollection 2023.
2
Modulation of the gut microbiota: a focus on treatments for irritable bowel syndrome.
Postgrad Med. 2017 Nov;129(8):872-888. doi: 10.1080/00325481.2017.1383819. Epub 2017 Oct 13.
4
The Role of Gut-Microbiota in the Pathophysiology and Therapy of Irritable Bowel Syndrome: A Systematic Review.
Cureus. 2022 Aug 16;14(8):e28064. doi: 10.7759/cureus.28064. eCollection 2022 Aug.
5
Probiotics for Irritable Bowel Syndrome: Clinical Data in Children.
J Pediatr Gastroenterol Nutr. 2016 Jul;63 Suppl 1:S25-6. doi: 10.1097/MPG.0000000000001220.
6
Functional abdominal pain disorders in children.
Expert Rev Gastroenterol Hepatol. 2018 Apr;12(4):369-390. doi: 10.1080/17474124.2018.1438188. Epub 2018 Feb 16.
7
Current Treatment Options and Therapeutic Insights for Gastrointestinal Dysmotility and Functional Gastrointestinal Disorders.
Front Pharmacol. 2022 Jan 25;13:808195. doi: 10.3389/fphar.2022.808195. eCollection 2022.
8
Emerging Role of the Gut Microbiome in Irritable Bowel Syndrome.
Gastroenterol Clin North Am. 2021 Sep;50(3):523-545. doi: 10.1016/j.gtc.2021.03.003. Epub 2021 Jun 25.
9
Gut Microbiota and Chronic Constipation: A Review and Update.
Front Med (Lausanne). 2019 Feb 12;6:19. doi: 10.3389/fmed.2019.00019. eCollection 2019.
10
The gut microbiome and irritable bowel syndrome: State of art review.
Arab J Gastroenterol. 2018 Sep;19(3):136-141. doi: 10.1016/j.ajg.2018.02.008. Epub 2018 Jun 20.

引用本文的文献

本文引用的文献

2
The Role of Short Chain Fatty Acids in Irritable Bowel Syndrome.
J Neurogastroenterol Motil. 2022 Oct 30;28(4):540-548. doi: 10.5056/jnm22093.
3
Efficacy of Oral Psyllium in Pediatric Irritable Bowel Syndrome: A Double-Blind Randomized Control Trial.
J Pediatr Gastroenterol Nutr. 2023 Jan 1;76(1):14-19. doi: 10.1097/MPG.0000000000003622. Epub 2022 Sep 22.
4
Vitamin D supplementation for irritable bowel syndrome: A systematic review and meta-analysis.
J Gastroenterol Hepatol. 2022 Jun;37(6):993-1003. doi: 10.1111/jgh.15852. Epub 2022 Apr 20.
5
AGA Clinical Practice Update on the Role of Diet in Irritable Bowel Syndrome: Expert Review.
Gastroenterology. 2022 May;162(6):1737-1745.e5. doi: 10.1053/j.gastro.2021.12.248. Epub 2022 Mar 23.
7
Peppermint oil effects on the gut microbiome in children with functional abdominal pain.
Clin Transl Sci. 2022 Apr;15(4):1036-1049. doi: 10.1111/cts.13224. Epub 2022 Jan 20.
8
The Gut Microbiome Alterations in Pediatric Patients with Functional Abdominal Pain Disorders.
Microorganisms. 2021 Nov 15;9(11):2354. doi: 10.3390/microorganisms9112354.
9
Skills or Pills: Randomized Trial Comparing Hypnotherapy to Medical Treatment in Children With Functional Nausea.
Clin Gastroenterol Hepatol. 2022 Aug;20(8):1847-1856.e6. doi: 10.1016/j.cgh.2021.10.029. Epub 2021 Oct 27.
10
Effect of a synbiotic on functional abdominal pain in childhood.
Caspian J Intern Med. 2021 Mar;12(2):194-199. doi: 10.22088/cjim.12.2.194.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验